Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Account Payables (2019 - 2025)

Pulmonx has reported Change in Account Payables over the past 7 years, most recently at $121000.0 for Q3 2025.

  • Quarterly Change in Account Payables fell 91.02% to $121000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Sep 2025, up 61.41% year-over-year, with the annual reading at $2.3 million for FY2024, 760.29% up from the prior year.
  • Change in Account Payables was $121000.0 for Q3 2025 at Pulmonx, down from $2.1 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.6 million in Q3 2021 and troughed at -$2.8 million in Q4 2021.
  • The 5-year median for Change in Account Payables is $121000.0 (2025), against an average of $264894.7.
  • Year-over-year, Change in Account Payables crashed 2111.11% in 2022 and then skyrocketed 42900.0% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$2.8 million in 2021, then surged by 70.54% to -$830000.0 in 2022, then crashed by 104.58% to -$1.7 million in 2023, then skyrocketed by 58.78% to -$700000.0 in 2024, then surged by 117.29% to $121000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Account Payables are $121000.0 (Q3 2025), $2.1 million (Q2 2025), and $505000.0 (Q1 2025).